Pricing Log in Create free account
Saturday 17 October 2026 Export MRNA’s income statement to Excel — free account

Moderna, Inc.

MRNA Healthcare Biotechnology

Moderna, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 39.9% from fiscal 2024. In the quarter to June 2026, revenue grew 2.11%, EPS grew 7.51%, free cash flow grew 38.9% and total debt rose 1,765.6%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100.

218.01 18.49 −7.82%
Market cap
$94.4B
P/E
0.0×
Fwd P/E
−5.5×
Dividend yield
—
F-score
3/9
Altman Z
2.46
Beneish M
−3.52
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Moderna, Inc. (MRNA) Book value per share

Alert me on Book value per share

Moderna, Inc.'s book value per share at the end of fiscal 2025 was 22.2×, down 21.7% from 28.4× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 17.0×. Over the past ten years it has ranged from −8.5× (fiscal 2017) to 48.5× (fiscal 2022); the current reading is higher than 60% of that period. Moderna, Inc. ranks 38th of 612 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 22.2× (21.67%)
FY2024 28.4× (21.72%)
FY2023 36.3× (25.28%)
FY2022 48.5× 38.28%
FY2021 35.1× 422.17%
FY2020 6.7× 89.38%
FY2019 3.5× (81.19%)
FY2018 18.9× —
FY2017 −8.5× —
FY2016 −5.5× —

Quarterly newest first

Period Book value per share Change
Jun 2026 17.0× (9.42%)
Mar 2026 18.8× (15.66%)
Dec 2025 22.2× (7.05%)
Sep 2025 23.9× (1.24%)
32 more quarters

Against its own ten years

Low −8.5× High 48.5×
Ten-year median 20.6×
Current reading's percentile 60

Book value per share against peers

Company Book value per share
REGN Regeneron Pharmaceuticals, Inc. compare 308×
ARGX argenex SE compare 135×
VRTX Vertex Pharmaceuticals Incorporated compare 79.8×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 46.4×
RPRX Royalty Pharma PLC compare 22.0×
MRNA Moderna, Inc. 17.0×
RVMD Revolution Medicines, Inc. compare 12.4×
ALNY Alnylam Pharmaceuticals, Inc. compare 10.1×
ROIV Roivant Sciences Ltd. compare 6.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on MRNA